FrancophonIA/ELRC3.0 huggingface dataset:
English: In case the adhesive residue is left over on your skin, gently soak the area with warm water and mild soap or use baby oil to remove it. Alcohol or other dissolving liquids (nail polish remover or other solvents) should not be used.
Danish: I tilfælde af, at limrester er tilovers på din hud, opblød forsigtigt området med varmt vand og mild sæbe eller brug babyolie til at fjerne det.
English: Pregnancy, breast feeding and fertility
Danish: Graviditet, amning og frugtbarhed
English: In animals, rivastigmine is excreted into milk.
Danish: Rivastigmin udskilles i mælken hos dyr.
English: - Renal impairment: No dose adjustment is necessary for patients with renal impairment.
Danish: • Nedsat nyrefunktion: Dosisjustering er ikke nødvendig hos patienter med nedsat nyrefunktion.
English: Store in the original package in order to protect from light.
Danish: Opbevares i originalemballagen for at beskytte mod lys.
English: This leaflet was last revised in {month YYYY}
Danish: Denne indlægsseddel blev senest ændret <{MM/ÅÅÅÅ}>
English: Initial dose Treatment is started with 4.6 mg/24 h.
Danish: Initialdosis Behandlingen indledes med 4,6 mg/24 timer.
English: Treatment should be temporarily interrupted if gastrointestinal adverse reactions are observed until these adverse reactions resolve.
Danish: Hvis der observeres gastrointestinale bivirkninger, bør behandlingen afbrydes midlertidigt, indtil bivirkningerne er ophørt.
English: After switching to 4.6 mg/24 h transdermal patches, provided these are well tolerated after a minimum of four weeks of treatment, the dose of 4.6 mg/24 h should be increased to 9.5 mg/24 h, which is the recommended effective dose.
Danish: Efter at have skiftet til 4,6 mg/24 timer depotplastre, bør dosis på 4,6 mg/24 timer, forudsat at denne er veltolereret efter minimum 4 ugers behandling, øges til 9,5 mg/24 timer, som er den anbefalede effektive dosis.
English: - Keep this medicine out of the sight and reach of children.
Danish: - Opbevar dette lægemiddel utilgængeligt for børn.
English: Patients and their caregivers must be instructed on important administration instructions for Rivastigmine 3M Health Care Ltd. transdermal patch (see section 4.2).
Danish: Patienterne og deres omsorgspersoner skal instrueres i vigtige administrationsinstruktioner for Rivastigmine 3M Health Care Ltd. depotplaster (se pkt.
English: Table 1
Danish: Tabel 1
English: How to remove your Rivastigmine 3M Health Care Ltd. transdermal patch Gently pull at one edge of the patch to remove it slowly from the skin.
Danish: Sådan tager du dit Rivastigmine 3M Health Care Ltd. depotplaster af Træk forsigtigt i kanten af plasteret for at fjerne det langsomt helt fra huden.
English: - Fast or uneven heartbeat - High blood pressure - Fits (seizures) - Liver disorders (yellow skin, yellowing of the whites of the eyes, abnormal darkening of the urine or unexplained nausea, vomiting, tiredness and loss of appetite) - Changes in tests which show how well the liver is working - Feeling restless
Danish: Leversygdomme (gulfarvet hud, gulfarvning af det hvide i øjnene, unormalt mørk urin eller uforklarlig kvalme, opkastning, træthed eller appettitløshed) Ændringer i tests, som viser hvor godt leveren fungerer
English: - Do not cut the patch into pieces.
Danish: - Klip ikke plasteret i stykker.
English: How to apply your Rivastigmine 3M Health Care Ltd. transdermal patch Rivastigmine 3M Health Care Ltd. patches are transparent to translucent, plastic patches that stick to the skin.
Danish: Sådan sætter du dit Rivastigmine 3M Health Care Ltd. depotplaster på Rivastigmine 3M Health Care Ltd. depotplastre er tynde, uigennemsigtigte plast-plastre, som klæber til huden.
English: However, due to increased exposure in these populations as observed with the oral forms, dosing recommendations to titrate according to individual tolerability should be closely followed as patients with clinically significant renal impairment might experience more adverse reactions (see sections 4.4 and 5.2).
Danish: På grund af øget biotilgængelighed hos disse patienter observeret med de orale formuleringer, bør anbefalingerne vedrørende titrering i henhold til individuel tolerance dog følges nøje, da patienter med klinisk signifikant nedsat nyrefunktion kan opleve flere bivirkninger (se pkt.
English: EXPIRY DATE
Danish: UDLØBSDATO Udløbsdato
English: Unchanged rivastigmine is found in trace amounts in the urine; renal excretion of the metabolites is the major route of elimination after transdermal patch administration.
Danish: Renal udskillelse af metabolitterne er den væsentligste udskillelsesvej efter administration af depotplaster.
English: Patients with severe hepatic impairment have not been studied (see sections 4.4 and 5.2).
Danish: Patienter med stærkt nedsat leverfunktion er ikke blevet undersøgt (se pkt.
English: The active substance of Rivastigmine 3M Health Care Ltd. is rivastigmine.
Danish: Det aktive lægemiddel i Rivastigmine 3M Health Care Ltd. er rivastigmin.
English: STATEMENT OF ACTIVE SUBSTANCE(S) 1 transdermal patch of 4.15 cm2 contains 7.17 mg rivastigmine and delivers 4.6 mg/24 h.
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER 1 depotplaster på 4,15 cm2 indeholder 7,17 mg rivastigmin og afgiver 4,6 mg/24 timer.
English: The patient's weight should be monitored during therapy with Rivastigmine 3M Health Care Ltd. transdermal patches.
Danish: Patientens vægt bør overvåges under behandling med Rivastigmine 3M Health Care Ltd. depotplastre.
English: Special populations: - Patients with body weight below 50 kg may experience more adverse reactions and may be more likely to discontinue due to adverse reactions (see section 4.2).
Danish: • Patienter med en legemsvægt på under 50 kg kan opleve flere bivirkninger og har større risiko for at måtte afbryde behandlingen på grund af bivirkninger (se pkt.
English: Rivastigmine 9.5 mg/24 h n Mean n Mean DLSM 95% CI p-value
Danish: DLSM 95% CI p-værdi
English: The metabolite-to-parent AUC∞ ratio was around 0.7 after transdermal patch administration versus 3.5 after oral administration, indicating that much less metabolism occurred after dermal compared to oral treatment.
Danish: M/P-ratio for AUC∞ var omkring 0,7 efter depotplaster administration mod 3,5 efter oral administration.
English: If you have to undergo surgery whilst using Rivastigmine 3M Health Care Ltd. transdermal patches, tell your doctor that you are using them because they may exaggerate the effects of some muscle relaxants during anaesthesia.
Danish: Hvis du skal opereres, mens du er i behandling med Rivastigmine 3M Health Care Ltd. depotplastre, skal du fortælle det til din læge, da Rivastigmine 3M Health Care Ltd. kan forstærke effekten af muskelafslappende midler under bedøvelse.
English: Application site skin reactions (e.g. application site erythema, application site pruritus, application site oedema, application site dermatitis, application site irritation), asthenic conditions (e.g. fatigue,
Danish: Hudreaktioner på applikationsstedet (f.eks. erytem på applikationsstedet, kløe ved applikationsstedet, ødem ved applikationsstedet, dermatitis på applikationsstedet, irritation ved applikationsstedet), asteniske lidelser (f.eks. træthed, asteni), pyreksi, vægttab
English: - Rivastigmine 3M Health Care Ltd. 4.6 mg/24 h transdermal patches: Each patch releases 4.6 mg of rivastigmine per 24 hours, is 4.15 cm2 and contains 7.17 mg of rivastigmine.
Danish: - Rivastigmine 3M Health Care Ltd. 4,6 mg/24 timer depotplaster: Hvert depotplaster frigiver 4,6 mg rivastigmin pr. 24 timer, er 4,15 cm2 og indeholder 7,17 mg rivastigmin.
English: Although less pronounced than with the oral formulation, exposure to rivastigmine (Cmax and AUC) increased over-proportionally by a factor of 2.6 and 4.9 when escalating from 4.6 mg/24 h to 9.5 mg/24 h and to 13.3 mg/24 h, respectively.
Danish: Eksponeringen for rivastigmin (Cmax og AUC) steg overproportionalt med en faktor på 2,6 og 4,9 ved skift fra 4,6 mg/24 timer til henholdsvis 9,5 mg/24 timer og til 13,3 mg/24 timer, hvilket er mindre udtalt end ved den orale formulering.
English: The most commonly reported skin irritation events during the first 24 weeks of the double-blind period with rivastigmine 13.3 mg/24 h transdermal patches and rivastigmine 9.5 mg/24 h transdermal patches, respectively were application site erythema (5.7% vs 4.6%) and application site pruritus (3.6% vs 2.8%).
Danish: De hyppigst rapporterede hændelser med hudirritationer i løbet af de første 24 uger af den dobbeltblindede periode med rivastigmin 13,3 mg/24 timer depotplastre og rivastigmin 9,5 mg/24 timer depotplastre, var henholdsvis erytem på applikationsstedet (5,7% mod 4,6%) og kløe på applikationsstedet (3,6% mod 2,8%).
English: LIST OF EXCIPIENTS Also contains polyester, ethyl vinyl acetate, acrylate copolymer adhesive and isopropyl myristate.
Danish: LISTE OVER HJÆLPESTOFFER Indeholder også polyester, ethylvinylacetat, acrylatcopolymerklæbemiddel og isopropylmyristat.
English: Table 4
Danish: Tabel 4
English: Polyester
Danish: Dæklag: -Polyester
English: Concomitant administration of rivastigmine with commonly prescribed medicinal products, such as antacids, antiemetics, antidiabetics, centrally acting antihypertensives, beta blockers, calcium channel blockers, inotropic agents, antianginals, non-steroidal anti-inflammatory agents, oestrogens, analgesics, benzodiazepines and antihistamines, was not associated with an alteration in the kinetics of rivastigmine or an increased risk of clinically relevant untoward effects.
Danish: Eksempler på disse lægemidler er: antacida, antiemetika, antidiabetika, centralt virkende antihypertensiva, betablokkere, calciumkanalblokkere, inotrope midler, midler mod angina pectoris, non-steroide antiinflammatoriske stoffer, østrogener, analgetika, benzodiazepiner og antihistaminer.
English: Reapplication to the exact same skin location within 14 days should be avoided to minimise the potential risk of skin irritation.
Danish: For at mindske risikoen for hudirritation bør der gå mindst 14 dage mellem, at plasteret påføres samme sted på huden.
English: After a minimum of four weeks of treatment and if well tolerated according to the treating physician, the dose of 4.6 mg/24 h should be increased to 9.5 mg/24 h, the daily recommended effective dose, which should be continued for as long as the patient continues to demonstrate therapeutic benefit.
Danish: Efter mindst fire ugers behandling, og hvis denne dosis ifølge den behandlende læge tåles godt, bør dosis med 4,6 mg/24 timer øges til 9,5 mg/24 timer, som er den anbefalede virksomme dosis, anvendes så længe der er terapeutisk effekt for patienten.
English: - If the patch falls off, a new one should be applied for the rest of the day, then it should be replaced at the same time as usual the next day.
Danish: - Hvis plasteret faller af, skal et nyt plaster påføres for resten af dagen.
English: What Rivastigmine 3M Health Care Ltd. looks like and contents of the pack The transdermal patches are rectangular with rounded corners, approximately 2.5 cm by 1.8 cm (Rivastigmine 3M Health Care Ltd. 4.6 mg/24 h transdermal patch) or 3.5 cm by 2.6 cm (Rivastigmine 3M Health Care Ltd. 9.5 mg/24 h transdermal patch).
Danish: Rivastigmine 3M Health Care Ltd. udseende og pakningsstørrelser Depotplastrene er rektangulære med afrundede hjørner, plastre, cirka 2,5 cm x 1,8 cm Rivastigmine 3M Health Care Ltd. 4,6 mg/24 timer depotplaster) eller 3,5 cm x 2,6 cm (Rivastigmine 3M Health Care Ltd. 9,5 mg/24 timer depotplaster).
English: - Then press the patch firmly in place for at least 30 seconds using the palm of the hand to make sure that the edges stick well.
Danish: - Tryk herefter plastret godt fast i mindst 30 sekunder ved hjælp af håndfladen for at sikre, at hjørnerne sidder fast.
English: Table 2
Danish: Tabel 2
English: - Rivastigmine 3M Health Care Ltd. 9.5 mg/24 h transdermal patches: Each patch releases 9.5 mg of rivastigmine per 24 hours, is 8.3 cm2 and contains 14.33 mg of rivastigmine.
Danish: - Rivastigmine 3M Health Care Ltd. 9,5 mg/24 timer depotplaster: Hvert depotplaster frigiver 9,5 mg rivastigmin pr. 24 timer, er 8,3 cm2 og indeholder 14,33mg rivastigmin.
English: CONDITIONS OR RESTRICTIONS REGARDING SUPPLY
Danish: BETINGELSER ELLER BEGRÆNSNINGER MED HENSYN TIL SIKKER OG
English: There was no relevant accumulation of rivastigmine or the metabolite NAP226-90 in plasma in patients with Alzheimer's disease, except that plasma levels were higher on the second day of transdermal patch therapy than on the first.
Danish: Der var ingen relevant akkumulering af rivastigmin eller metabolitten NAP226-90 i plasma hos patienter med Alzheimers demens.
English: The percentages decreased in both rivastigmine 13.3 mg/24 h transdermal patch and rivastigmine 9.5 mg/24 h transdermal patch treatment groups over time (>24 weeks): application site erythema (0.8% vs. 1.6%) and application site pruritus (0.4% vs. 1.2%), respectively.
Danish: Procentdelen faldt hos behandlingsgruppen over tid (>24 uger) med både rivastigmin 13,3 mg/24 timer depotplaster og rivastigmin 9,5 mg/24 timer depotplaster: Henholdsvis erytem på applikationsstedet (0,8% mod 1,6%) og kløe på applikationsstedet (0,4% mod 1,2%).
English: - The other ingredients are polyester, ethyl vinyl acetate, acrylate copolymer adhesive and isopropyl myristate.
Danish: - Øvrige indholdsstoffer polyester, ethylvinylacetat, acrylatcopolymerklæbemiddel og isopropylmyristat.
English: Hepatitis, elevated liver function tests Skin and subcutaneous tissue disorders Common Not known
Danish: Lever og galdeveje Hud og subkutane væv
English: The use of this medicinal product is contraindicated in patients with known hypersensitivity to the active substance rivastigmine, to other carbamate derivatives or to any of the excipients listed in section 6.1.
Danish: Kendt overfølsomhed over for det aktive stof rivastigmin, over for andre carbamatderivater eller over for et eller flere af hjælpestofferne anført i pkt.
English: Nervous system disorders Common
Danish: Nervesystemet
English: - Only wear one Rivastigmine 3M Health Care Ltd. patch at a time and replace the patch with a new one after 24 hours.
Danish: - Brug kun ét plaster ad gangen og udskift plasteret med et nyt efter 24 timer.
English: If you forget to use Rivastigmine 3M Health Care Ltd.
Danish: Hvis du har glemt at bruge Rivastigmine 3M Health Care Ltd.
English: • Do not cut the patch into pieces.
Danish: • Klip ikke plasteret i stykker.
English: Table 3
Danish: Tabel 3
English: Weight loss
Danish: Nedsat leverfunktion
English: DB-week 48 Value Change 264 4.1 268 4.9 -0.8 (-2.1,
Danish: Ændring 264 4,1 268 4,9 -0,8 (-2,1, 0,5) 0,227
English: There is no relevant use of Rivastigmine 3M Health Care Ltd. in the paediatric population in the treatment of Alzheimer's disease.
Danish: Der er ingen relevante indikationer for brug af Rivastigmine 3M Health Care Ltd. til behandling af Alzheimers sygdom hos børn og teenagere.
English: - A patient on a dose of 6 mg/day oral rivastigmine can be switched to 4.6 mg/24 h transdermal patches.
Danish: • En patient, som får en dosis på 6 mg/dag oral rivastigmin, kan skiftes til 4,6 mg/24 timer depotplastre.
English: - The patch should be pressed down firmly for at least 30 seconds using the palm of the hand until the edges stick well.
Danish: - Plasteret trykkes godt ned i mindst 30 sekunder med håndfladen , indtil kanterne sidder godt fast.
English: The backing layer is transparent to translucent and labelled with “R5” (Rivastigmine 3M Health Care Ltd. 4.6 mg/24 h transdermal patch) or “R10” (Rivastigmine 3M Health Care Ltd. 9.5 mg/24 h transdermal patch).
Danish: Bagsidelaget er gennemsigtigt til gennemskinneligt og mærket med "R5" (Rivastigmine 3M Health Care Ltd. 4,6 mg/24 timer depotplaster) eller 3,5 cm x 2,6 cm (Rivastigmine 3M Health Care Ltd. 9,5 mg/24 timer depotplaster).
English: - A patient on a dose of 12 mg/day oral rivastigmine can be switched to 9.5 mg/24 h transdermal patches.
Danish: • En patient, som får en dosis på 12 mg/dag oral rivastigmin, kan skiftes til 9,5 mg/24 timer depotplastre.
English: Package Leaflet: Information for the user Rivastigmine 3M Health Care Ltd. 4.6 mg/24 h transdermal patch Rivastigmine 3M Health Care Ltd. 9.5 mg/24 h transdermal patch rivastigmine
Danish: Indlægsseddel: Information til brugeren Rivastigmine3M Health Care Ltd. 4,6 mg/24 timer depotplaster Rivastigmine 3M Health Care Ltd. 9,5 mg/24 timer depotplaster rivastigmin
English: 4.6 mg
Danish: 10 cm2
English: Each patch is sealed in a pouch that protects it until you are ready to put it on. Do not open the pouch or remove a patch until just before you apply it.
Danish: Hvert depotplaster ligger i sit eget brev, som beskytter det, indtil du er klar til at sætte det på.
English: • Press the patch firmly in place for at least 30 seconds using the palm of the hand.
Danish: • Tryk plasteret fast på huden i mindst 30 sekunder ved brug af håndfladen.
English: - if you have gastrointestinal reactions such as feeling sick (nausea), being sick (vomiting) and diarrhoea.
Danish: - hvis du har gener fra mave-tarmkanalen, såsom kvalme, opkastning og diarré.
English: • Take off the previous patch before putting ONE new patch on.
Danish: • Fjern det gamle plaster før ET nyt plaster påsættes.
English: What you need to know before you use Rivastigmine 3M Health Care Ltd.
Danish: Det skal du vide, før du begynder at bruge Rivastigmine 3M Health Care Ltd.
English: - Hepatic impairment: Patients with clinically significant hepatic impairment might experience more adverse reactions (see sections 4.2 and 5.2).
Danish: • Nedsat nyrefunktion: Patienter med klinisk signifikant nedsat nyrefunktion kan opleve flere bivirkninger (se pkt.
English: Rivastigmine 9.5 mg/24 h
Danish: Rivastigmin depotplastre 9,5 mg/24 t
English: - If you have any further questions, ask your doctor, pharmacist or nurse.
Danish: Er du i tvivl, så spørg lægen, på apoteket eller sundhedspersonalet.
English: Mean change at week 24  SD -0.1  9.1 p-value versus placebo * p≤0.05 versus placebo
Danish: 24  SD p-værdi versus placebo * p≤0,05 versus placebo
English: STATEMENT OF ACTIVE SUBSTANCE(S) 1 transdermal patch of 8.3 cm2 contains 14.33 mg rivastigmine and delivers 9.5 mg/24 h.
Danish: 1 depotplaster på 8,3 cm2 indeholder 14,33 mg rivastigmin og afgiver 9,5 mg/24 timer.
English: - if you have, or have ever had, an active stomach ulcer.
Danish: - hvis du har eller har haft mavesår.
English: - if you have, or have ever had, difficulties in passing urine.
Danish: - hvis du har eller har haft vandladningsbesvær.
English: INFORMATION IN BRAILLE Rivastigmine 3M Health Care Ltd. 4.6 mg/24 h
Danish: INFORMATION I BRAILLESKRIFT Rivastigmine 3M Health Care Ltd. 4,6 mg/24 timer
English: Possible side effects
Danish: Andre bivirkninger
English: INFORMATION IN BRAILLE Rivastigmine 3M Health Care Ltd. 9.5 mg/24 h
Danish: INFORMATION I BRAILLESKRIFT Rivastigmine 3M Health Care Ltd. 9,5 mg/24 timer
English: Uncommon (may affect up to 1 in 100 people) - Uneven heart rate (e.g. fast heart rate) - Difficulty sleeping - Accidental falls
Danish: Ikke almindelig (kan forekomme hos op til 1 ud af 100 patienter) Uregelmæssig hjerterytme (f.eks. hurtig hjerterytme (puls))
English: ADAS-cog scores: A negative difference in DLSM indicates greater improvement in Rivastigmine 13.3 mg/24 h as compared to Rivastigmine 9.5 mg/24 h.
Danish: ADAS-cog score: En negativ forskel i DLSM indikerer større forbedring med rivastigmin 15 cm2
English: No study was conducted with rivastigmine transdermal patches in subjects with hepatic impairment.
Danish: Der er ikke udført nogen undersøgelser med rivastigmin depotplastre hos patienter med nedsat leverfunktion.
English: The fluctuation index (FI), a measure of the relative difference between peak and trough concentrations ((Cmax-Cmin)/Cavg), was 0.58 for rivastigmine 4.6 mg/24 h transdermal patches, 0.77 for rivastigmine 9.5 mg/24 h transdermal patches and 0.72 for rivastigmine 13.3 mg/24 h transdermal patches, thus demonstrating a much smaller fluctuation between trough and peak concentrations than for the oral formulation (FI = 3.96 (6 mg/day) and 4.15 (12 mg/day)).
Danish: Fluktuationsindekset (FI), som er et mål for den relative forskel mellem højeste og laveste koncentration ((Cmax-Cmin)/Cavg), var 0,58 for rivastigmin 4,6 mg/24 timer depotplastre, 0,77 for rivastigmin 9,5 mg/24 timer depotplastre og 0,72 for rivastigmin
English: Rare
Danish: Almindelig
English: ADCS-IADL scores: A positive difference in DLSM indicates greater improvement in Rivastigmine 13.3 mg/24 h as compared to Rivastigmine 9.5 mg/24 h.
Danish: ADCS-IADL score: En positiv forskel i DLSM indikerer større forbedring med rivastigmin 15 cm2
English: EU/1/14/911/005 [7 pouches] EU/1/14/911/006 [30 pouches] EU/1/14/911/007 [60 pouches] EU/1/14/911/008 [90 pouches]
Danish: EU/1/14/911/005 [7 breve] EU/1/14/911/006 [30 breve] EU/1/14/911/007 [60 breve] EU/1/14/911/008 [90 breve]
English: EU/1/14/911/001 [7 pouches] EU/1/14/911/002 [30 pouches] EU/1/14/911/003 [60 pouches] EU/1/14/911/004 [90 pouches]
Danish: EU/1/14/911/001 [7 breve] EU/1/14/911/002 [30 breve] EU/1/14/911/003 [60 breve] EU/1/14/911/004 [90 breve]
English: Contact with the eyes should be avoided after handling Rivastigmine 3M Health Care Ltd. transdermal patches (see section 5.3).
Danish: Undgå kontakt med øjnene efter håndtering af Rivastigmine 3M Health Care Ltd. depotplastre (se pkt.
English: If you are pregnant, the benefits of using Rivastigmine 3M Health Care Ltd. transdermal patches must be assessed against the possible effects on your unborn child. Rivastigmine 3M Health Care Ltd. should not be used during pregnancy unless clearly necessary.
Danish: Hvis du er gravid, skal fordelen ved at bruge Rivastigmine 3M Health Care Ltd. afvejes i forhold til de mulige bivirkninger på fosteret.
English: Aggression
Danish: Hudirritation
English: Other adverse reactions Care must be taken when prescribing Rivastigmine 3M Health Care Ltd. transdermal patches:
Danish: Der skal udvises forsigtighed ved ordination af Rivastigmine 3M Health Care Ltd. depotplastre:
English: - to patients with sick sinus syndrome or conduction defects (sino-atrial block, atrio-ventricular block) (see section 4.8) - to patients with active gastric or duodenal ulcers or patients predisposed to these conditions because rivastigmine may cause increased gastric secretions (see section 4.8) - to patients predisposed to urinary obstruction and seizures because cholinomimetics may induce or exacerbate these diseases.
Danish: • til patienter med aktivt mavesår eller sår på tolvfingertarmen eller patienter, som er prædisponeret for sådanne sygdomme, da rivastigmin kan medføre øget mavesyresekretion (se pkt.
English: Polyester and ethyl vinyl acetate
Danish: Bagsidelag: - Polyester og ethylvinylacetat
English: You should not breast-feed during treatment with Rivastigmine 3M Health Care Ltd. transdermal patches.
Danish: Du må ikke amme, mens du er i behandling med Rivastigmine 3M Health Care Ltd. depotplastre.
English: Check with your doctor, pharmacist or nurse if you are not sure.
Danish: Spørg lægen eller på apoteket, hvis der er noget, du er i tvivl om.
English: Psychiatric disorders Common
Danish: Psykiske forstyrrelser
English: NAP226-90) and bodyweight was observed in Alzheimer's dementia patients.
Danish: Der blev observeret en sammenhæng mellem eksponering for aktive stoffer ved steady state (rivastigmin og metabolit NAP226-90) og legemsvægt hos patienter med Alzheimers demens.
English: - Press the patch firmly in place for at least 30 seconds using the palm of the hand.
Danish: - Tryk plasteret fast på huden i mindst 30 sekunder ved brug af håndfladen.
English: Fall
Danish: Fald
English: Other medicines and Rivastigmine 3M Health Care Ltd.
Danish: Brug af anden medicin sammen med Rivastigmine 3M Health Care Ltd.
English: Urinary tract infection Metabolism and nutrition disorders Common
Danish: Metabolisme og ernæring
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Rivastigmine 3M Health Care Ltd. 9.5 mg/24 h transdermal patch rivastigmine
Danish: LÆGEMIDLETS NAVN, STYRKE OG/ELLER ADMINISTRATIONSVEJ(E) Rivastigmine 3M Health Care Ltd. 9,5 mg/24 timer depotplaster rivastigmin